Jerry Chang, CEO

Jerry has >20 years of experience in technology development and commercialization with key roles in operations, product development, quality assurance, and regulatory affairs. His career includes the invention, development and launch of numerous novel surgical implants and sterilization platforms, aseptic formulation & production of biological materials, and quality oversight of manufacturing, validation and testing operations for companies including BioD, LLC (now Integra LifeSciences: IART), Vigilant Bioservices, Transplant Technologies of Texas (acquired by Globus Medical [GMED]), Regeneration Technologies (now RTI Surgical: RTIX), and he was a founding member and Director of Operations and Product Development at AxoGen Inc. (AXGN). Jerry is currently a member of the Upstate Carolina Angel Network and is an Affiliate Faculty Member and Chair of the External Advisory Board at the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida.